Ottewell, Penelope D <br/><br/>
Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.  [electronic resource] 

 -  International journal of cancer  Jan 2010 
 - 522-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.24756  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--genetics<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Cell Cycle--drug effects<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Tumor<br/>Diphosphonates--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Imidazoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Mice<br/>Mice, Nude<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Burden<br/>Xenograft Model Antitumor Assays<br/>Zoledronic Acid